GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (STU:CJH) » Definitions » ROE % Adjusted to Book Value

CanSino Biologics (STU:CJH) ROE % Adjusted to Book Value : -5.00% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics ROE % Adjusted to Book Value?

CanSino Biologics's ROE % for the quarter that ended in Jun. 2024 was -4.35%. CanSino Biologics's PB Ratio for the quarter that ended in Jun. 2024 was 0.87. CanSino Biologics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -5.00%.


CanSino Biologics ROE % Adjusted to Book Value Historical Data

The historical data trend for CanSino Biologics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics ROE % Adjusted to Book Value Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -1.83 6.25 -5.68 -24.68 -5.01

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.01 -37.16 -18.67 -5.00 -

Competitive Comparison of CanSino Biologics's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanSino Biologics's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's ROE % Adjusted to Book Value falls into.


';

CanSino Biologics ROE % Adjusted to Book Value Calculation

CanSino Biologics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-7.52% / 1.50
=-5.01%

CanSino Biologics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.35% / 0.87
=-5.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanSino Biologics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics Business Description

Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines